skip to Main Content
  • Français
  • Deutsch
  • Italiano

Find our

News

MammoRisk® News

Find our latest news.
A question ? Contact us at contact@predilife.com

Artificial Intelligence – Collaboration with the Radiology Department of the AP-HP Sorbonne University Hospital -Tenon Paris

A study conducted in early 2019 by Professor Isabelle Thomassin-Naggara and her colleagues, using DenSeeMammo…

lire la suite
Predilife announces its collaboration with LILT – Italian League for the Fight against Breast Cancer Milano Monza e Brianza –

Predilife is pleased to announce the collaboration between Predilife and LILT - Italian League for…

lire la suite
“Breast cancer risk assessment combined with a PRS”

Access the results presented in San Antonio.

lire la suite
Discover the first issue of the Predilife newsletter

Find here the first issue of the Predilife newsletter "Predict to prevent".

lire la suite
MammoRisk® is a Class I medical device manufactured by Predilife. It is a regulated health product which carries the CE mark under these regulations. 
Read the user manual carefully before use. MammoRisk® is not a diagnostic test. MammoRisk® is a breast cancer risk assessment test. 
Back To Top